Lili Nsongo Ph.D. (Aurélie)

Lili (Aurélie) Nsongo, PhD, MBA has a diverse work experience spanning various roles in the fields of equity research, biomedical research, and laboratory work. Lili (Aurélie) currently holds the position of Vice President - Equity Research, Biotechnology at Leerink Partners since February 2023. Prior to that, they served as an Associate - Equity Research, Biotechnology at the same company from May 2021 to February 2023. From December 2016 to May 2021, they held the role of Vice President, Research & Innovation at Delos™. Earlier in their career, they worked at Mayo Clinic in multiple roles, including Science Writer from December 2015 to December 2016, Biomedical Researcher from July 2012 to December 2016, and Laboratory Technician from May 2011 to July 2012.

Lili (Aurélie) Nsongo, PhD, MBA's education history begins with their bachelor's degree in Genetics from Université Paris Cité, which they completed in 2011. Lili (Aurélie) then pursued further studies at the same institution, obtaining a Magistere Européen de Génétique in the field of study between 2010 and 2011. Continuing their education, Lili went on to UVSQ Université de Versailles Saint-Quentin-en-Yvelines, where they focused on Biology from 2009 to 2010, and Medicine from 2008 to 2009.

Later, Lili pursued a Doctor of Philosophy (PhD) degree in Neurobiology and Neurosciences from Mayo Clinic Graduate School of Biomedical Sciences, completing their studies from 2012 to 2016. In 2018 to 2019, they attended Purdue University, obtaining a Master of Business Administration (MBA).

Lili also holds additional certifications, including a Business and Financial Modeling Certification from The Wharton School, obtained in 2019. Lili (Aurélie) also possesses certifications such as SIE, Series 63, Series 86, and Series 87, from FINRA, though the specific dates of obtaining these certifications are not provided.